A subgroup analysis of a randomized trial showed that patients with previously treated metastatic renal cell carcinoma had significant improvement in progression-free survival when they received everolimus.
Motzer RJ, Escudier B, Oudard S, et al.
Advertisement
Articles by Motzer RJ, Escudier B, Oudard S, et al.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
ASCO 2026 Ushers In a New Era for Pancreatic Cancer, Expands Targeted Therapy Options Across the GI Spectrum
2
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
3
FDA Flashback: Breast Cancer Decisions and News From May 2026
4
Dr Mathews on Updated Data From the RAINFOL-01 Trial in Advanced Ovarian Cancer
5